eMedicine Specialties > Obstetrics and Gynecology > Reproductive Endocrinology and Infertility
Luteinizing Hormone Deficiency: Differential Diagnoses & Workup
Updated: Feb 12, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Differential Diagnoses
| Amenorrhea, Primary | Luteal Phase Dysfunction |
| Amenorrhea, Secondary | Ovarian Insufficiency |
| Anovulation | Polycystic Ovarian Syndrome |
| Hyperthyroidism | Prolactinoma |
Workup
Laboratory Studies
The basic laboratory evaluation for females or males suspected of having luteinizing hormone (LH) deficiency includes serum levels of thyroid-stimulating hormone (TSH), prolactin (PRL), LH, follicle-stimulating hormone (FSH), and estradiol. Low or normal LH and FSH levels in the presence of low estradiol suggest a hypothalamic problem. A pituitary problem is most commonly associated with elevated PRL levels.
Imaging Studies
When hypothalamic or pituitary dysfunction is suspected, the most important imaging study is magnetic resonance imaging (MRI) of the head to determine the presence of a tumor or other abnormality (see Media File 2).
Other Tests
Olfactory testing
When Kallmann syndrome is suspected, olfactory testing can be performed. Screening tests can be performed using vanilla or aromatic oils (eg, wintergreen, cinnamon). Quantitative tests have been developed using either scratch-and-sniff panels or serial dilutions of odorants such as dimethyl sulfide or acetic acid. Perhaps the most widely used clinical olfactory test is the University of Pennsylvania Smell Identification Test (UPSIT) that uses scratch-and-sniff panels.
Screening for eating disorders
Patients suspected of have an eating disorders can be screened for by asking the British SCOFF questions:
- Do you ever make yourself SICK when you feel uncomfortably full?
- Do you worry you have lost CONTROL over how much you eat?
- Have you lost more than 14 pounds (ONE stone's worth of weight) within the last 3 months?
- Do you believe you are FAT when others say you are too thin?
- Would you say that FOOD dominates your life?
When infertile women are suspected of having luteal phase deficiency (LPD), the luteal phase should be evaluated.
- Duration (normal ≥12 d): Luteal phase duration is measured as the time from the onset of the LH surge detected in the urine to the onset of menses or as the number of days of basal body temperature rise (see Media File 1).
- Peak luteal phase progesterone (normal ≥12 ng/mL): Peak luteal phase serum progesterone is obtained 1 week after ovulation.
Procedures
Transsphenoidal resection is used to remove pituitary macroadenomas (>1 cm in diameter) that remain symptomatic or increase in size despite medical treatment.
Luteal phase endometrial biopsies were used in the past to diagnose LPD. However, because of the day-to-day variation in the histologic findings within the luteal phase, biopsies are now rarely performed for this purpose.
Histologic Findings
Pituitary adenomas are rarely malignant. The most common benign adenomas are prolactinomas (70%). Approximately 25% of adenomas do not secrete any hormone (null cell tumors). The remainder secrete TSH, GH, ACTH, and in rare cases, LH and FSH.
More on Luteinizing Hormone Deficiency |
| Overview: Luteinizing Hormone Deficiency |
Differential Diagnoses & Workup: Luteinizing Hormone Deficiency |
| Treatment & Medication: Luteinizing Hormone Deficiency |
| Follow-up: Luteinizing Hormone Deficiency |
| Multimedia: Luteinizing Hormone Deficiency |
| References |
| « Previous Page | Next Page » |
References
Cahill DJ, Wardle PG, Harlow CR, Hull MG. Onset of the preovulatory luteinizing hormone surge: diurnal timing and critical follicular prerequisites. Fertil Steril. Jul 1998;70(1):56-9. [Medline].
Fluker M, Fisher S. Anovulation and ovulatory dysfunction. In: Falcone T, Hurd WW. Clinical reproductive medicine and surgery. New York: Elsevier; 2007:277-86.
Kalantaridou SN, Makrigiannakis A, Zoumakis E, Chrousos GP. Stress and the female reproductive system. J Reprod Immunol. Jun 2004;62(1-2):61-8. [Medline].
Lofrano-Porto A, Barra GB, Giacomini LA, Nascimento PP, Latronico AC, Casulari LA. Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med. Aug 30 2007;357(9):897-904. [Medline].
Loret de Mola JR. Amenorrhea. In: Falcone T, Hurd WW, eds. Clinical reproductive medicine and surgery. New York: Elsevier; 2007:233-52.
Mahutte NG, Ouhilal S. Hypothalamic-pituitary-ovarian axis & control of the menstrual cycle. In: Falcone T, Hurd WW, eds. Clinical reproductive medicine and surgery. First ed. New York: Elsevier; 2007:1-16.
McComb JJ, Qian XP, Veldhuis JD, J McGlone J, Norman RL. Neuroendocrine responses to psychological stress in eumenorrheic and oligomenorrheic women. Stress. Mar 2006;9(1):41-51. [Medline].
Patel SS, Bamigboye V. Hyperprolactinaemia. J Obstet Gynaecol. Jul 2007;27(5):455-9. [Medline].
Pritts SD, Susman J. Diagnosis of eating disorders in primary care. Am Fam Physician. Jan 15 2003;67(2):297-304. [Medline].
Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. Aug 30 2007;357(9):863-73. [Medline].
Sehu S, Reddy K, Fleseriu M. Management of pituitary, thyroid and adrenal disorders. In: Falcone T, Hurd WW, eds. Clinical reproductive medicine and surgery. New York: Elsevier; 2007:311-34.
Seidenfeld ME, Rickert VI. Impact of anorexia, bulimia and obesity on the gynecologic health of adolescents. Am Fam Physician. Aug 1 2001;64(3):445-50. [Medline].
Sharma RK. Physiology of Male Gametogenesis. In: Falcone T, Hurd WW, eds. Clinical reproductive medicine and surgery. New York: Elsevier; 2007:73-84.
Solnik JM, Sanfilippo JS. Normal puberty and pubertal disorders. In: Falcone T, Hurd WW, eds. Clinical reproductive medicine and surgery. New York: Elsevier; 2007:157-70.
Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R. Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology. 1987;12(2):131-40. [Medline].
Yao MWM, Batchu K. Oogenesis. In: Falcone T, Hurd WW, eds. Clinical reproductive medicine and surgery. New York: Elsevier; 2007:51-72.
Further Reading
Keywords
Kallmann syndrome, hypothalamic suppression, hypogonadotropic hypogonadism, pituitary dysfunction, hyperprolactinemia, luteal phase deficiency, luteinizing hormone deficiency, LH, follicle-stimulating hormone, FSH, thyroid-stimulating hormone, TSH, human chorionic gonadotropin, hCG, gonadotropin-releasing hormone, GnRH, hormone replacement therapy
Differential Diagnoses & Workup: Luteinizing Hormone Deficiency